PT Indosat Tbk. First Quarter 2007 Results. 1Q 2007 Results Page 1

Size: px
Start display at page:

Download "PT Indosat Tbk. First Quarter 2007 Results. 1Q 2007 Results Page 1"

Transcription

1 PT Indosat Tbk First Quarter 2007 Results 1Q 2007 Results Page 1

2 Key Highlights in 1Q 2007 (YoY) Operating revenues (New Reporting Format) increased by 30.2% Operating revenues (Old Reporting Format) increased by 19.14% Fixed Data (MIDI) revenues increased by 8.3% Cellular Subscribers growth by 39.1% IDD traffic increased by 25.8 % EBITDA increased by 19.8% Net Income increased by 26% 1Q 2007 Results Page 2

3 Key Business Segment Cellular Business Fixed Data (MIDI) Fixed Telecomm (Voice) 77% of Total Revenues 13% of Total Revenues 10% of Total Revenues Matrix Postpaid for high end users Indosat International Leased Circuit International Frame Relay/ATM VSATs Wholesale Internet Access IDD 001 Premium IDD Mentari Prepaid for general users IM3 Prepaid for the young & trendy Domestic Leased Circuit Domestic Frame Relay/ATM VSATs Corporate Solutions IDD 008 Budget IDD FlatCall 016 Flat Rate IDD 3G HSDPA services for wireless broadband IP Virtual Private Network Dedicated and Dial Up Internets Wi-Fi & HotSpots StarOne Fixed Wireless Access GlobalSave VoIP Service 1Q 2007 Results Page 3

4 Wireless Market 1Q-07 ESIA 20% Mobile 8 24% Indosat FWA 5% CDMA 12% FLEXI 51% XL 15% GSM 88% ISAT 27% New License Holders Hutchison CP Tel Maxis TSEL 58% Source: Company reports and estimates 1Q 2007 Results Page 4

5 Cellular Subscribers Composition In thousands Cellular Subscribers Subs composition as end of Mar-07 Prepaid 95% 16,705 14,512 9,754 Postpaid 5% ARPU (Rupiah) 217, ,006 1,316 50,448 58,836 48,501 55,507-1, Prepaid Postpaid Blended 1Q 2007 Results Page 5

6 Data Communications & Broadband (In billion rupiah) Fixed Data (MIDI) Revenue 1,694 1,484 1,902 Fixed Data (MIDI) revenues increased 8.3% (YoY). The main driver of growth is the increase from both corporate IP-related services such as IP-VPN, and Non IP based services such as high speed leased lines Key Growth Performances in 1Q 2007 are: International High Speed Leased Circuit 180.1% Domestic High Speed Leased Circuit 48.6% IP-VPN 103.2% 1Q 2007 Results Page 6

7 Fixed (Voice) Telecommunication 1,000, , , , , , , , , ,000 0 Trend in IDD Traffic (in thousands minutes)) 78% 84% 87% 22% 16% 13% 87% 84% 13% 16% Outgoing Incoming Revenues Composition (1Q 2007) Cellular 77% FIXED (Voice) 10% Fixed Data (MIDI) 13% Fixed (Voice) telecommunication contributed 10% to operating revenues mostly from IDD revenues. The revenues increased as the impact of the increase in revenue from International calls (IDD) and Fixed Wireless Access services. 1Q 2007 Results Page 7

8 Cellular Network Coverage Indosat Nationwide Cellular Coverage Non Java; 34% Number of BTS 1Q 2007 Java; 66% BTS 2G & 3G BSC MSC 1Q Q ,971 7, Q 2007 Results Page 8

9 Financial Performance (YoY) In billion Rupiah Operating Revenues Rp 3, % (New Reporting Format) Operating Revenues Rp 3, % (Old Reporting Format) Operating Income Rp 1, % EBITDA Rp 2, % Other Income (Expenses) Rp (329.4) 13.2% Net Income Rp % 1Q 2007 Results Page 9

10 Revenues and EBITDA growth Top Line 14.5% growth YoY Maintain EBITDA Margin (new reporting format) within the range of 57 59% Positive trend continue to show up since April 2006 Operating Revenues (Old reporting format) (Rp billion) 10,430 11,590 12,239 (Rp billion) EBITDA and EBITDA Margin (Old) 7, % 6,732 6, % 58.1% 2,900 3, % 57.6% 1,685 2,018 Operating Revenues (New reporting format) (Rp billion) 10,430 11,590 12,239 (Rp billion) EBITDA and EBITDA Margin (New) 58.1% 57.7% 57.6% 58.1% 6,732 7,052 6,017 2,900 3, % 1,685 2,018 1Q 2007 Results Page 10

11 Sound Balance Sheet EBITDA Margin (Old Reporting Format) 58,4% 58,1% 58,1% Interest Coverage 559.2% 542.6% 585.4% 524.7% 686.8% 57,7% 57,6% Debt to EBITDA Net Debt to Equity 54.4% 56.7% 53.8% 54.3% 191.9% 224.5% 208.7% 213.5% 184.3% 41.6% Sufficient resources and flexibility to support plans and actions 1Q 2007 Results Page 11

12 Committed Shareholders Indosat s shares are majority owned by public investors (44.90%) ST Telemedia through Indonesia Communications Limited owns (39.96%) and Indonesia Communications Pte Limited owns (0.85%) Indonesian Government owns 14.29% including Series A share Republic of Indonesia Public 40.81% 44.90% 14.29% Listed on the JSX, SSX and NYSE Note: (1) Per 31 December Q 2007 Results Page 12

13 Key Initiatives in 1Q 2007 Provided 7,666 BTS on air at the end of 1Q 2007 Continued innovative marketing and promotion initiatives by commencing Mentari Seru Improved distribution scheme and mechanism to support product availability and market expansion 1Q 2007 Results Page 13

14 Guidance for 2007 Net Additional 5-6 million customers Total Revenue growth by 20% Maintain EBITDA Margin (Old Reporting Format) within 57-59% Maintain current market share Fixed Data (MIDI) to grow by 15-20% Deploy BTS Capital Expenditures of at least USD 1 Billion 1Q 2007 Results Page 14

15 Recent Development Bond issuance of total Rp 3 Trillion Indosat gained approval from BAPEPAM to issue Indosat Bond V of Rp2.6 Trillion and Sukuk Ijarah II of Rp400 Billion in Indonesian Rupiah to support our aggressive network expansion. Indosat Bond V are divided by two series i.e, series A will mature in seven years and series B will mature in ten years. Indosat Sukuk Ijarah II will mature in seven years. Mentari Tariff Program Marketing promotion to strengthen Mentari positioning. This initiative consist of competitive local call Launched 3.5G services in 16 cities Indosat lauched 3.5G services in 16 cities which are Jakarta, Surabaya, Bandung, Yogyakarta, Medan, Balikpapan, Semarang, Denpasar, Batam, Makassar, Jepara, Kudus, Cepu, Salatiga, Magelang dan Cilacap. With Full HSDPA technology, data transfer can reach up to 3.6 Mbps or nine times faster than regular 3G. 1Q 2007 Results Page 15

16 Thank You 1Q 2007 Results Page 16

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Telekom Austria Group Results for the 1st Quarter May 27, 2003 Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those

More information

Telekom Austria Group Results for the First Quarter May 16, 2007

Telekom Austria Group Results for the First Quarter May 16, 2007 Telekom Austria Group Results for the First Quarter 2007 May 16, 2007 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those

More information

APPLIANCE TELECOMMUNICATIONS

APPLIANCE TELECOMMUNICATIONS May 2001 1 DEVICE CRT PDP CRT components APPLIANCE Air Conditioner Refrigerator Washing machine Cooking appliance DISPLAY& MEDIA TV / Monitor CD-ROM DVD products VCR / PC / PCB TELECOMMUNICATIONS Switching

More information

Summary of Results for the First Half of FY2015/3

Summary of Results for the First Half of FY2015/3 Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial

More information

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-MARCH 2014 Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011 Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai

More information

Global Remote Cardiac Monitoring Market: Size, Trends & Forecasts ( )

Global Remote Cardiac Monitoring Market: Size, Trends & Forecasts ( ) Global Remote Cardiac Monitoring Market: Size, Trends & Forecasts (2016-2020) #910680 $800 55 pages In Stock Report Description Scope of the Report The report entitled Global Remote Cardiac Monitoring

More information

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014 Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains

More information

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor

More information

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland

More information

Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit JANUARY-JUNE 2014 Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-JUNE 2013 Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

Enel Américas 1Q 2018 results

Enel Américas 1Q 2018 results Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation

More information

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase

More information

Public Expose. Jakarta, 21 December 2012

Public Expose. Jakarta, 21 December 2012 Public Expose Jakarta, 21 December 2012 Overview Established in 1911 as a plantation and processing natural rubber company, PT Bakrie Sumatera UNSP Sales (IDR Billion) Plantations Tbk ( UNSP ) now evolving

More information

Interim report Second quarter 2017 and subsequent events (Unaudited)

Interim report Second quarter 2017 and subsequent events (Unaudited) SERODUS ASA Interim report Second quarter 2017 and subsequent events (Unaudited) August 2017 2017-08-15 Q2-2017 report ABOUT SERODUS Serodus is a private biotech company with a focus on diabetic comorbidities

More information

FY2016 1H Results. Cookpad Inc.

FY2016 1H Results. Cookpad Inc. FY2016 1H Results Cookpad Inc. 1 1H Highlights Premium Service -Premium Service revenue increased by 39.6% YoY. -Number of premium members grew by 12.0% YoY to exceed 1.85 million. Advertising -Advertising

More information

Korean Airlines Q Results

Korean Airlines Q Results Korean Airlines 2010 2Q Results 2010. 8. 13 1 Disclaimer This presentation is for informational purposes only, contains preliminary financial and other information about Korean Air Lines Co., Ltd. and

More information

Q Investor Kit JANUARY-MARCH 2013

Q Investor Kit JANUARY-MARCH 2013 Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009 FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)

More information

DELICA D:5 ACTIVE GEAR 0

DELICA D:5 ACTIVE GEAR 0 DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion

More information

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( ) Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,

More information

Investor Day Lausanne, September 27, 2018

Investor Day Lausanne, September 27, 2018 Investor Day Lausanne, September 27, 2018 Jacek Olczak Chief Operating Officer OPERATING AROUND THE ADULT CONSUMER 2 Operating Around the Adult Consumer CC RRPs PMI Combustible Cigarette Performance Reduced-Risk

More information

ELICA 2012 Q3 RESULTS. November 14,

ELICA 2012 Q3 RESULTS. November 14, ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation

More information

HALOZYME REPORTS SECOND QUARTER 2018 RESULTS

HALOZYME REPORTS SECOND QUARTER 2018 RESULTS Contacts: Robert H. Uhl Managing Director Westwicke Partners, LLC 858-356-5932 robert.uhl@westwicke.com Laurie Stelzer 858-704-8222 ir@halozyme.com FOR IMMEDIATE RELEASE HALOZYME REPORTS SECOND QUARTER

More information

RAI increases 3Q13 earnings on strong operating performance; tightens full-year EPS guidance

RAI increases 3Q13 earnings on strong operating performance; tightens full-year EPS guidance Contact: Investor Relations: Morris Moore (336) 741-3116 Media: Jane Seccombe (336) 741-5068 Reynolds American Inc. P.O. Box 2990 Winston-Salem, NC 27102-2990 RAI 2013-13 RAI increases 3Q13 earnings on

More information

Brookings Institution, March 4, 2013 Laura Papi and IMF India Team

Brookings Institution, March 4, 2013 Laura Papi and IMF India Team Brookings Institution, March, 13 Laura Papi and IMF India Team The views expressed in this presentation are those of the authors and should not be attributed to the International Monetary Fund, its Executive

More information

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update -Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109

More information

Investor Presentation

Investor Presentation Investor Presentation Forward Looking Statements The information presented herein may contain projections, predictions, estimates and other forwardlooking statements within the meaning of Section 27A of

More information

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance Contact: Investor Relations: Morris Moore (336) 741-3116 Media: Jane Seccombe (336) 741-5068 Reynolds American Inc. P.O. Box 2990 Winston-Salem, NC 27102-2990 RAI 2013-10 RAI: Strong key-brands performance

More information

China Insulin Industry Report, Jan. 2011

China Insulin Industry Report, Jan. 2011 China Insulin Industry Report, 2010 Jan. 2011 This report analyzes the status, competition pattern and development direction of the insulin industry Focuses on the operation and development prospect of

More information

Corporate Presentation October New growth cycle and value innovation

Corporate Presentation October New growth cycle and value innovation Corporate Presentation October 2017 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev 3 Strategic competitive advantages 4 Financial and Operational

More information

Knowledge Discovery and Data Mining Applied to Engineering Applications

Knowledge Discovery and Data Mining Applied to Engineering Applications Knowledge Discovery and Data Mining Applied to Engineering Applications Shirley Williams The University of Reading 25th September 2001 (c) Shirley Williams, 2001 1 Overview The process Understanding the

More information

Forward Looking Information

Forward Looking Information Vital Signs, Inc. Forward Looking Information Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned

More information

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,

More information

6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store

6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store Actual Store Low Price & Great Value $5,6, 6.% CAP Rate Open & paying rent--available for immediate sale Lower price point and great value Offered free & clear; loans available today with as little as

More information

View Report Details. Global Coronary Stent Market

View Report Details. Global Coronary Stent Market View Report Details Global Coronary Stent Market ------------------------------------------------- 2013 View Report Details Executive Summary Coronary heart diseases are nowadays becoming more and more

More information

Supplementary Data of Consolidated Financial Statements for the third quarter ended December 31, 2016

Supplementary Data of Consolidated Financial Statements for the third quarter ended December 31, 2016 Supplementary Data of Financial Statements for the third quarter ended December 31, 2016 January 31, 2017 NITTO DENKO CORPORATION CONTENTS Page Business 1 Segment Information 2 Segment Information By Geographic

More information

Coloplast A/S. Investor presentation 1H 2005/06

Coloplast A/S. Investor presentation 1H 2005/06 Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound

More information

CENTRALE. Monetary. compared. domestic. million.

CENTRALE. Monetary. compared. domestic. million. CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased

More information

Second Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1

Second Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1 Second Quarter and First Half 2011 Conference Call 29 July, 2011 SORIN GROUP Presentation 1 DISCLAIMER This presentation contains management preliminary estimates and forward-looking statements, including

More information

William Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations

William Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General

More information

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( ) Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications

More information

Welcome to LG Electronics

Welcome to LG Electronics Welcome to LG Electronics April 21, 2004 As a note, this presentation has been prepared based on internal audited figures and final figures may change due to the results of independent auditors review.

More information

Q Investor Kit January December 2014

Q Investor Kit January December 2014 Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January

More information

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue

More information

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Forward Looking Statement This presentation includes forward-looking statements, including financial projections, relating

More information

Corporate Response to Mark H. Goldberg & Associates Report:

Corporate Response to Mark H. Goldberg & Associates Report: Corporate Response to Mark H. Goldberg & Associates Report: Impact of BCE/MTS Transaction on SaskTel A high level risk assessment December 12, 2016 1 Executive Summary Mark H. Goldberg & Associates delivered

More information

Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016

Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016 Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016 1 Forward Looking Statements Forward Looking Statements Some of the information presented here today may contain projections or other

More information

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries The Guidance Notes provide guidance for the Borrower on the application of the Environmental and Social Standards (ESSs), which form part of the World Bank s 2016 Environmental and Social Framework. The

More information

Singapore Exchange Limited 1Q FY2009 Financial Results

Singapore Exchange Limited 1Q FY2009 Financial Results Singapore Exchange Limited 1Q FY2009 Financial Results 15 October 2008 Singapore Exchange 1 1Q FY2009 Financial Performance NPAT fell 35% from record 1Q FY2008 Operating profit flat compared to 4Q FY2008

More information

For personal use only

For personal use only HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening

More information

Consolidated: Financial Summary

Consolidated: Financial Summary FY2010 First Quarter Financial Results SUZUKI MOTOR CORPORATION 3 August 2010 Consolidated: Financial Summary Page2 FY2010 1Q FY2009 1Q (2010/4-6) (2009/4-6) Change Net sales 656.3 577.1 +79.2 +13.7% Operating

More information

Summary Statement of Financial Position (consolidated)

Summary Statement of Financial Position (consolidated) 2012. 5. 3. 1 Disclaimer This presentation is for informational purposes only, contains preliminary financial and other information about Korean Air Lines Co., Ltd. and is subject to updating, revision,

More information

Effective Technology and Its Economic Benefits: The Case of Colonoscopy

Effective Technology and Its Economic Benefits: The Case of Colonoscopy Effective Technology and Its Economic Benefits: The Case of Colonoscopy Ross C. DeVol, Chief Research Officer Milken Institute The 2015 Dialogue for Action: Expanding Access Through Innovation Renaissance

More information

FIRSTQUARTER2018 RESULTSPRESENTATION

FIRSTQUARTER2018 RESULTSPRESENTATION FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection

More information

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce

More information

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results July 31, 2015 NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET- AMES, Iowa, July 31,

More information

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018 CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm

More information

Spine and Orthopedic ASC Development

Spine and Orthopedic ASC Development Performance, Efficiency, Achievement, Knowledge Spine and Orthopedic ASC Development October 22, 2015 22nd Annual Meeting The Business and Operations of ASCs Kenny Hancock, President and Chief Development

More information

Merrill Lynch conference. Matthew Emmens, CEO Shire plc September 20, 2007

Merrill Lynch conference. Matthew Emmens, CEO Shire plc September 20, 2007 Merrill Lynch conference Matthew Emmens, CEO Shire plc September 20, 2007 THE SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 Statements included herein that are not historical

More information

Q2 INVESTOR KIT JANUARY-JUNE 2011

Q2 INVESTOR KIT JANUARY-JUNE 2011 Q2 INVESTOR KIT JANUARY-JUNE 2011 Swedish Match reporting segments Reporting segments following the transaction with STG on October 1, 2010 Snus and snuff - Swedish snus in Scandinavia and US - US moist

More information

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( ) Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United

More information

2015 Investor Conference

2015 Investor Conference 2015 Investor Conference ACCELERATING PROFITABLE GROWTH Jill Schaaf President, Renal Care Teeramanas Tanaekakarapong, ESRD Patient, Bangkok, Thailand Becoming The Global Leader In Renal Care Our Global

More information

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012 ASL MARINE DBS Vickers Pulse of Asia Roadshow 10 January 2012 Presentation Outline Group Overview 1Q FY2012 Financial Review (3 months ended 30 September 2011) Operations Review - Shipbuilding - Shiprepair

More information

Leading Intimate Healthcare

Leading Intimate Healthcare 21 May 2008 1 Leading Intimate Healthcare Investor presentation H1 2007/08 2 Agenda Introduction to Coloplast First 6 months 2007/08 in headlines Outlook for 2007/08 Strategic targets Leading intimate

More information

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK Small-Cap Research February 2, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive

More information

This is a licensed product of Ken Research and should not be copied

This is a licensed product of Ken Research and should not be copied 1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market

More information

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018 ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates

More information

Third-quarter results 2013

Third-quarter results 2013 Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen

More information

BALCHEM CORPORATION. Q Investor Relations Presentation

BALCHEM CORPORATION. Q Investor Relations Presentation BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life

More information

Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria

Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi

More information

Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights

Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights May 8, 2018 Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights Company booked net ZILRETTA sales of $2.2 million in Q1 Positive developments in Medicare reimbursement

More information

Insert Cover Image using Slide Master View Do not distort. Anti-Diabetic Pharmaceuticals Market - India

Insert Cover Image using Slide Master View Do not distort. Anti-Diabetic Pharmaceuticals Market - India Insert Cover Image using Slide Master View Do not distort Anti-Diabetic Pharmaceuticals Market - India March 2012 Eecutive Summar Market Drivers and Challenges Drug Regulation and Patents Global Market

More information

Presentation First quarter 2006

Presentation First quarter 2006 Immunity for Life TM Presentation First quarter 2006 CEO Gunnar Rørstad CFO Finn Samuelsen 10 May 2006 Highlights - operations Inclusion of patients almost completed in the the phase II clinical trial

More information

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars

More information

Financial Presentation

Financial Presentation Financial Presentation Certain of the statements that will be made during this meeting, as well as statements contained in our 2006 Annual Report to Shareholders and Annual Report on Form 10-K filed with

More information

Investor Presentation

Investor Presentation Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities

More information

6. If I already own another brand Videophone, can I use it with the ACN Digital Phone Service? No.

6. If I already own another brand Videophone, can I use it with the ACN Digital Phone Service? No. FAQs ACN Digital Phone Service General 1. What do I need in order to benefit from ACN Digital Phone Service? You will need the following to benefit from this innovative service: - A credit card for the

More information

Results Briefing. 15 ~ 17 May 2007

Results Briefing. 15 ~ 17 May 2007 Results Briefing 1Q Q & 3 Months ended 31 Mar. 2007 15 ~ 17 May 2007 Content Key highlights Financial Corporate Financial results Industry overview Q&A Appendix 2 2 Key Highlights for the Period Key Highlights

More information

The power of innovation to save lives

The power of innovation to save lives Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.

More information

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Forward-looking statements The forward-looking statements contained in this presentation,

More information

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders Contact: Investor Relations: Bob Bannon (336) 741-3359 Media: Jane Seccombe (336) 741-5068 Reynolds American Inc. P.O. Box 2990 Winston-Salem, NC 27102-2990 RAI 2016-22 RAI reports strong 2Q16 performance

More information

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion

More information

May 6, 2008 First Quarter 2008 Results

May 6, 2008 First Quarter 2008 Results SWEUB2227319CMDV7 May 6, 28 First Quarter 28 Results 1Q 28: Improved results in a challenging environment Page 2 Strong loan growth at 34.2% yoy Accelerated deposit growth at 31% yoy; improved loans /

More information

Mount Prospect, Illinois

Mount Prospect, Illinois 1 Mile 3 Mile 5 Mile Population 1,189 1,659 337,66 Avg. HH Income $17, $85,16 $9,441 Landmark Walgreens Corporate HQ O Hare Airport Downtown Chicago Drive Time 1 minutes 15 minutes 35 minutes Walgreens

More information

GAVI, THE VACCINE ALLIANCE

GAVI, THE VACCINE ALLIANCE #vaccineswork GAVI, THE VACCINE ALLIANCE Natasha Bilimoria December 2016 National Academy of Sciences www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and protect people s health by increasing

More information

Jefferies Healthcare Conference June 6, 2018

Jefferies Healthcare Conference June 6, 2018 Jefferies Healthcare Conference June 6, 2018 Forward-Looking Statements Some of the statements included in this presentation, particularly those regarding the commercialization and ongoing clinical development

More information

Genomic Health. Kim Popovits, Chairman, CEO and President

Genomic Health. Kim Popovits, Chairman, CEO and President Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and

More information

First Quarter Results to March 31, Shire plc April 25, 2008

First Quarter Results to March 31, Shire plc April 25, 2008 First Quarter Results to March 31, 2008 Shire plc April 25, 2008 THE SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 Statements included herein that are not historical

More information

Dabur India Ltd. BUY CMP (Rs.) 277 Target (Rs.) 344 Potential Upside 24% Investment Rationale. Volume No.. I Issue No. 40. September 8 th, 2015

Dabur India Ltd. BUY CMP (Rs.) 277 Target (Rs.) 344 Potential Upside 24% Investment Rationale. Volume No.. I Issue No. 40. September 8 th, 2015 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15. Volume No.. I Issue No. 40. Dabur India Ltd. September 8 th, 2015 BSE Code: 500096 NSE Code: DABUR Reuters Code:

More information

DARA Reports Year-End 2012 Financial Results

DARA Reports Year-End 2012 Financial Results April 1, 2013 DARA Reports Year-End 2012 Financial Results Company Provides a Commercial Portfolio and Development Pipeline Business Update RALEIGH, NC -- (MARKETWIRE) -- 04/01/13 -- DARA BioSciences,

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator

More information

UCB, with a strong year 2017, is reinforcing a solid foundation for investing in future growth

UCB, with a strong year 2017, is reinforcing a solid foundation for investing in future growth Brussels (Belgium), February 018 7:00 (CET) regulated information UCB Full Year Report 017: UCB, with a strong year 017, is reinforcing a solid foundation for investing in future growth Positive growth

More information

Altria Group Inc. Ticker: MO

Altria Group Inc. Ticker: MO Altria Group Inc. Ticker: MO Business Description Altria Group Inc. through its subsidiaries manufactures and sells cigarettes, other tobacco products, machine-made large cigars and pipe tobacco. It also

More information

Q Investor Kit January December 2015

Q Investor Kit January December 2015 Q4 2015 Investor Kit January December 2015 Summary and Overview 2 Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local

More information

For personal use only

For personal use only Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for

More information